Know Cancer

or
forgot password

Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer


Phase 1/Phase 2
21 Years
90 Years
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information

Randomized Trial of Optimal Type of Aerobic Training in Breast Cancer


In this study we want to compare the effect of high-intensity to moderate-intensity aerobic
training, relative to attention-control, on peak oxygen consumption.

This study will include women who are at least 21 years old, an interval of no longer than 5
years following completion of primary therapy, life expectancy of greater than 6 months,
sedentary, willingness to be randomized, and signed consent form prior to all study
assessments.


Inclusion Criteria:



- At least 21 years old

- An interval of at least 1 year following completion of primary therapy

- An interval of no longer than 5 years following completion of primary therapy.

- Estimated life expectancy > 6 months

- Ability to read and understand English

- Primary attending oncologist approval

- Sedentary

- Willingness to be randomized

- Signed informed consent form prior to initiation of study-related procedures

Exclusion Criteria:

- Presence of a concurrent, actively treated other malignancy or history of other
malignancy treated within the past three years.

- Presence of metastatic disease

- No contraindication to a maximal exercise test or aerobic training and defined by the
American Thoracic Society

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care

Outcome Measure:

To compare the effect of high-intensity to moderate-intensity aerobic training, relative to attention-control, on peak oxygen consumption.

Outcome Description:

VO2 or peak oxygen consumption will be measured at 3 time-points. Baseline, mid-point (8 weeks), and post-intervention (16 weeks).

Outcome Time Frame:

3 time-points

Safety Issue:

Yes

Principal Investigator

Lee W Jones, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Duke University

Authority:

United States: Institutional Review Board

Study ID:

Pro00022294

NCT ID:

NCT01186367

Start Date:

August 2010

Completion Date:

March 2015

Related Keywords:

  • Breast Cancer
  • breast cancer
  • Breast Neoplasms

Name

Location
Duke Center for Living Durham, North Carolina  27710